A redox switch in angiotensinogen modulates angiotensin release

Nature

Volumn 468, Issue 7320, 2010, Pages 108-111

  Zhou, Aiwu ^a   Carrell, Robin W ^a   Murphy, Michael P ^b   Wei, Zhenquan ^a   Yan, Yahui ^a   Stanley, Peter L D ^a   Stein, Penelope E ^a   Pipkin, Fiona Broughton ^c   Read, Randy J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; RENIN;

BLOOD; CRYSTAL STRUCTURE; ENZYME ACTIVITY; INHIBITOR; OXIDATION; PEPTIDE; PREGNANCY; SURVIVAL;

ARTICLE; BLOOD PRESSURE; CIRCULATION; CONTROLLED STUDY; HYPERTENSIVE CRISIS; MOLECULAR INTERACTION; NITROSYLATION; OXIDATION REDUCTION REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANGIOTENSINOGEN; ANGIOTENSINS; BLOOD PRESSURE; CRYSTALLOGRAPHY, X-RAY; DISULFIDES; FEMALE; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RENIN;

EID: 78149267757     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09505     Document Type: Article

References (30)

1. Fyhrquist, F. & Saijonmaa, O. Renin-angiotensin system revisited. J. Intern. Med. 264, 224-236 (2008).
2. Stein, P. E., Tewkesbury, D. A. & Carrell, R. W. Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem. J. 262, 103-107 (1989).
3. Huber, R. & Carrell, R. W. Implications of the three-dimensional structure of a1-antitrypsinforstructureandfunctionofserpins. Biochemistry28, 8951-8966(1989).
4. Dickson, M. E. & Sigmund, C. D. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension 48, 14-20 (2006).
5. Kim, H. S. et al. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl Acad. Sci. USA 92, 2735-2739 (1995).
6. Inoue, I. et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 99, 1786-1797 (1997).
7. Dealwis, C. G. et al. X-ray analysis at 2. 0 Å resolution of mouse submaxillary renin complexed withadecapeptide inhibitorCH-66, basedonthe 4-16 fragment of rat angiotensinogen. J. Mol. Biol. 236, 342-360 (1994).
8. Nasir, U. M. et al. Two peaks in pH dependence of renin-angiotensinogen reaction. Biosci. Biotechnol. Biochem. 62, 338-340 (1998).
9. Streatfeild-James, R. M. et al. Angiotensinogen cleavage by renin: importance of a structurally constrained N-terminus. FEBS Lett. 436, 267-270 (1998).
10. Gimenez-Roqueplo, A. P., Celerier, J., Schmid, G., Corvol, P. & Jeunemaitre, X. Role of cysteine residues in human angiote nsinogen. Cys232 is required for angiotensinogen-pro major basic protein complex formation. J. Biol. Chem. 273, 34480-34487 (1998).
11. Kobori, H., Nangaku, M., Navar, L. G. & Nishiyama, A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 59, 251-287 (2007).
12. Nguyen, G. et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109, 1417-1427 (2002).
13. Brandes, N., Schmitt, S. & Jakob, U. Thiol-based redox switches in eukaryotic proteins. Antioxid. Redox Signal. 11, 997-1014 (2009).
14. Myatt, L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31 (suppl. A), S66-S69 (2010).
15. Dahm, C. C., Moore, K. & Murphy, M. P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J. Biol. Chem. 281, 10056-10065 (2006).
16. Stamler, J. S., Lamas, S. & Fang, F. C. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106, 675-683 (2001).
17. Wilcox, C. S. Oxidative stress and nitricoxide deficiency in the kidney: acritical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R913-R935 (2005).
18. Harrison, D. G. & Gongora, M. C. Oxidative stress and hypertension. Med. Clin. North Am. 93, 621-635 (2009).
19. Burton, G. J. & Jauniaux, E. Placental oxidative stress: from miscarriage to preeclampsia. J. Soc. Gynecol. Investig. 11, 342-352 (2004).
20. Hubel, C. A. Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med. 222, 222-235 (1999).
21. Sedeek, M. et al. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnantrats. Am. J. Hypertens. 21, 1152-1156 (2008).
22. Sibai, B., Dekker, G. & Kupferminc, M. Pre-eclampsia. Lancet365, 785-799 (2005).
23. Mistry, H. D., Wilson, V., Ramsay, M. M., Symonds, M. E. & Broughton Pipkin, F. Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension 52, 881-888 (2008).
24. Bulgan Kilicdag, E. et al. Oxidant-antioxidant system changes relative to placental-umbilical pathology in patients with preeclampsia. Hypertens. Pregnancy 24, 147-157 (2005).
25. Inoue, I. et al. Amutation of angiotensinogen in apatient with preeclampsia leads to altered kineticsof the renin-angiotensin system. J. Biol. Chem. 270, 11430-11436 (1995).
26. Hoffmann, D. S. et al. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia. Hypertension 51, 1058-1065 (2008).
27. McCoy, A. J. et al. Phasercrystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
28. Powell, N. A. et al. Benzyl ether structure-activity relationships in a series of ketopiperazine-based renin inhibitors. Bioorg. Med. Chem. Lett. 15, 4713-4716 (2005).
29. Murshudov, G. N., Vagin, A. A. &Dodson, E. J. Refinement of macromolecularstructures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
30. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D 60, 2126-2132 (2004).